查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1874005

細胞治療儀器市場

Cell Therapy Instrument Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

2024年細胞治療儀器市場價值約232.8億美元，預計2031年將成長至約599.8億美元。預計該市場從2031年到2032年將經歷15.4%的年複合成長率（CAGR），細胞治療儀器的自動化製造將呈現顯著趨勢。

細胞治療儀器市場分析

細胞療法是指將活細胞注射、植入或移植到患者體內。例如，在免疫療法中，癌症患者可能會接受T細胞注射。細胞療法的給藥方式多種多樣，從簡單的注射到使用專用設備的複雜外科植入物不等。細胞療法適用於多種疾病，其中癌症是影響神經系統最嚴重的疾病之一。其他應用包括心臟疾病（如心肌梗塞和心臟衰竭）、糖尿病、肌肉骨骼疾病、遺傳性疾病以及皮膚和軟組織創傷。

細胞治療儀器市場概覽

嵌合抗原受體（CAR）T細胞療法是最有前景的癌症治療方法之一，每年都有大量的臨床前和臨床試驗開展，以拓展其應用範圍。經過多年的研究，CAR-T細胞療法可望進一步發展。未來的研究不僅將探索自體和異體CAR-T細胞產品，還將探索新型體內CAR-T細胞基因療法及其在血液系統惡性腫瘤以外疾病的療效。

戰略洞察

細胞治療儀器市場的促進因素與機遇

細胞治療製造技術的進步

細胞療法研究的不斷發展，推動了細胞治療儀器的顯著進步，這些儀器旨在治療遺傳性疾病和增強免疫反應。多家公司提供試劑盒和酵素等必需耗材，而其他公司則提供各種細胞治療流程所需的儀器、設備和軟體。

使用專用設備對於生產T細胞、造血幹細胞（HSC）、間質幹細胞（MSC）、多能幹細胞（PSC）和神經幹細胞（NSC）等細胞療法至關重要。由於這些產品來自人類或動物細胞，因此保持無污染環境至關重要。因此，細胞療法中使用的儀器旨在防止污染並提高產量。康寧公司、日立化成先進治療解決方案有限公司、Cytiva（通用電氣公司旗下）、賽默飛世爾科技公司、Invetech和Miltenyi Biotec等知名公司已開發出用於細胞療法的各種儀器和耗材。

亞太和中東地區的生物技術產業正迅速擴張，這主要得益於私營和公共部門的大量投資和戰略舉措，尤其與北美和歐洲相比更是如此。例如，2024年12月，日本安斯泰來製藥公司宣布以30億美元收購基因治療公司Audentes Therapeutics。同樣，2024年11月，富士軟片公司宣布計劃在其合約開發和生產業務中投資約1.2億美元（130億日元）用於基因治療。此外，日本藥品和醫療器材管理局（PMDA）已批准兩款基因治療產品獲得「先驅」（Sakigake）認定，該認定類似於美國FDA的「突破性療法」認定和EMA的「優先藥物」（PRIME）認定，預計每年至少批准一種療法。亞洲各國本土企業的此類策略舉措預計將在不久的將來推動對細胞治療儀器的需求。

細胞治療儀器市場細分分析

細胞治療儀器市場的分析按疾病和服務提供者進行細分。

  • 市場按產品分為耗材、設備、系統和軟體，其中耗材部分在 2023 年佔據最大的市場佔有率。
  • 按細胞類型分類，市場分為人類細胞和動物細胞，其中熱塑性塑膠在 2023 年佔據最大的市場佔有率。
  • 按製程分類，市場分為細胞處理、製程監控和品質控制、細胞保存、分銷和處理，其中細胞處理部分在 2023 年佔據市場佔有率領先地位。
  • 以最終用戶分類，市場分為研究機構、生命科學研究公司和其他最終用戶，其中生命科學研究公司在 2023 年佔據最大的市場佔有率。

細胞治療儀器市場的地理分析

細胞治療儀器市場報告的地理範圍分為五個區域：北美、亞太、歐洲、中東和非洲以及南美/南美和中美洲。

美國是細胞治療儀器的最大且成長最快的市場，這主要得益於研發投入的增加以及包括基因療法、幹細胞療法和免疫療法在內的細胞療法的日益普及。此外，政府的支持也大大促進了細胞療法的發展，對市場擴張產生了正面影響。例如，美國基因與細胞治療學會（ASGCT）是一個公共組織，為從事基因和細胞治療的科學家、醫生、專業人士和患者權益倡導者提供會員資格，旨在提高人們對這些療法臨床應用的認知、教育和了解。

細胞治療儀器市場報告範圍

細胞治療儀器市場的最新發展

細胞治療儀器市場的評估是基於透過一手和二手研究收集的定性和定量資料，包括重要的企業出版物、協會資料和資料庫。該市場近期發展動態包括：

  • 賽默飛世爾科技公司與機器人公司 Multiply Labs 達成協議，將加強雙方在細胞療法生產自動化方面的合作。 （資料來源：賽默飛世爾科技公司，2024 年）
  • MaxCyte公司推出了ExPERT系列儀器，旨在為下一代細胞療法提供從概念到商業化的綜合技術平台。 （資料來源：MaxCyte公司，新聞稿，2024年）

細胞治療儀器市場報告覆蓋範圍及成果

題為《細胞治療儀器市場規模及預測（2021-2031）》的報告對市場進行了深入分析，涵蓋以下領域：

  • 涵蓋範圍內所有主要細分市場的全球、區域和國家層面的市場規模和預測。
  • 市場動態，包括促進因素、限制因素和主要機會。
  • 未來主要趨勢。
  • 全面的PEST/波特五力模型和SWOT分析。
  • 全球及區域市場分析，重點在於關鍵趨勢、主要參與者、法規及最新發展。
  • 產業格局和競爭分析，包括市場集中度、熱力圖分析、主要參與者和最新發展。
  • 公司詳細簡介。

目錄

第1章：引言

第2章：細胞治療儀器市場及主要結論

第3章：研究方法

  • 覆蓋範圍
  • 二手研究
  • 初步研究

第4章：全球細胞治療儀器及市場概況

  • 概述
  • PEST分析
    • 北美和PEST分析
    • 歐洲和PEST分析
    • 亞太地區及PEST分析
    • 中東和非洲 (MEA) 及 PEST 分析
    • 南美洲和中美洲（SCAM）及PEST分析
  • 專家意見

第5章：細胞治療儀器市場及主要市場動態

  • 市場促進因素
    • 細胞治療製造技術的不斷進步
    • 細胞療法獲準數量不斷增加
  • 市場限制
    • 細胞療法生產和細胞療法的高成本
  • 市場機遇
    • 發展中地區的成長機遇
  • 未來趨勢
    • 向自動化製造轉型
  • 影響分析

第6章：細胞治療儀器市場及全球分析

  • 全球細胞治療儀器標記物收入預測與分析
  • 全球細胞治療儀器市場（依地理分類）－預測與分析
  • 關鍵參與者的市場定位

第7章：細胞治療儀器市場分析及產品分類

  • 概述
  • 細胞治療儀器市場收入佔有率（按產品分類）（2024 年和 2031 年）
  • 消耗品
  • 裝置
  • 系統和軟體

第8章：細胞治療儀器市場分析及細胞類型分類

  • 概述
  • 細胞治療儀器市場收入佔有率（按細胞類型分類）（2024 年和 2031 年）
  • 人類細胞
  • 動物細胞

第9章：細胞治療儀器市場分析及製程分類

  • 概述
  • 細胞治療儀器市場收入佔有率（按製程分類）（2024 年和 2031 年）
  • 細胞處理
  • 過程監控和品質控制
  • 細胞保存、分發和處理

第10章：細胞治療儀器市場分析及最終用戶細分

  • 概述
  • 細胞治療儀器市場佔有率（按最終用戶分類），2024 年和 2031 年（%）
  • 研究機構
  • 生命科學研究公司
  • 其他最終用戶

第11章：細胞治療儀器市場分析及至2031年預測及地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
  • 中東和非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非
  • 南美洲和中美洲
    • 巴西
    • 阿根廷

第12章：新冠肺炎疫情對全球細胞治療儀器市場的影響

  • 北美洲
  • 歐洲
  • 亞太
  • 世界其他地區

第13章：行業概況

  • 概述
  • 市場中各公司採取的成長策略（%）
  • 有機發展
    • 概述
  • 無機物發展
    • 概述

第14章：公司簡介

  • THERMO FISHER SCIENTIFIC INC.
  • MERCK KGaA
  • Lonza
  • General Electric Company
  • Terumo Corporation
  • BD
  • Miltenyi Biotec
  • STEMCELL Technologies Inc.
  • Sartorius AG
  • Danaher (Beckman Coulter, Inc.)

第15章：附錄

簡介目錄
Product Code: TIPRE00003481

The market for cell therapy instruments was valued at approximately US$ 23.28 billion in 2024 and is projected to grow to around US$ 59.98 billion by 2031. This market is anticipated to experience a compound annual growth rate (CAGR) of 15.4% from 2031 to 2031, with a significant trend towards automated manufacturing in cell therapy instruments.

Analysis of the Cell Therapy Instrument Market

Cell therapy involves the injection, implantation, or grafting of living cells into a patient's body. For example, during immunotherapy, a cancer patient may receive T cell injections. The delivery methods for cell therapy instruments vary from simple injections to complex surgical implantations using specialized devices. Cell therapy is applicable to a wide range of conditions, with cancer being one of the most critical diseases affecting the nervous system. Other applications include cardiac issues (such as myocardial infarction and heart failure), diabetes, musculoskeletal disorders, genetic diseases, and skin and soft tissue wounds.

Overview of the Cell Therapy Instrument Market

Chimeric antigen receptor (CAR) T-cell therapy is one of the most promising cancer treatment methods, with numerous pre-clinical and clinical trials conducted annually to broaden its applications. After years of research, CAR-T cell therapy is set to expand further. Future developments will explore not only autologous and allogeneic products but also new in-vivo CAR-T cell gene therapies and their effectiveness in conditions beyond hematologic malignancies.

Strategic Insights

Drivers and Opportunities in the Cell Therapy Instrument Market

Advancements in Cell Therapy Manufacturing

Growing research in cell therapy has led to remarkable advancements in cell therapy instruments aimed at treating genetic disorders and enhancing immune responses. Various companies provide essential consumables like reagent kits and enzymes, while others offer the necessary instruments, equipment, and software for a wide array of cell therapy processes.

The use of specialized equipment is crucial for producing cell therapies such as T cells, hematopoietic stem cells (HSC), mesenchymal stem cells (MSC), pluripotent stem cells (PSC), and neural stem cells (NSC). Since these products are derived from human or animal cells, maintaining contamination-free conditions is vital. Consequently, the instruments used in cell therapies are designed to prevent contamination and facilitate increased production. Notable companies like Corning Incorporated, Hitachi Chemical Advanced Therapeutics Solutions, LLC, Cytiva (a General Electric Company), Thermo Fisher Scientific Inc., Invetech, and Miltenyi Biotec have developed various instruments and consumables for cell therapy applications.

The biotechnology industry in the Asia Pacific and Middle East regions is rapidly expanding, bolstered by significant investments and strategic initiatives from both private and public sectors, particularly in comparison to North America and Europe. For example, in December 2024, Astellas Pharma Inc. from Japan announced its acquisition of Audentes Therapeutics Inc., a gene therapy firm, for US$ 3 billion. Similarly, in November 2024, Fujifilm revealed plans to invest approximately US$ 120 million (13 billion yen) in gene therapy as part of its contract development and manufacturing segment. Additionally, the Japan Pharmaceutical Medical Device Agency (PMDA) approved two gene therapy products under the Sakigake designation, which is akin to the FDA's breakthrough therapy designation and the EMA's Priority Medicine (PRIME) designation, with expectations to approve at least one therapy annually. Such strategic moves by domestic players in Asian countries are likely to drive demand for cell therapy instruments in the near future.

Segmentation Analysis of the Cell Therapy Instrument Market

The analysis of the cell therapy instrument market is segmented by disorder and service providers.

  • The market is categorized by products into consumables, equipment, systems, and software, with the consumables segment holding the largest market share in 2023.
  • By cell type, the market is divided into human cells and animal cells, with thermoplastics representing the largest market share in 2023.
  • By process, the market is segmented into cell processing, process monitoring and quality control, cell preservation, distribution, and handling, with the cell processing segment leading in market share in 2023.
  • By end users, the market is categorized into research institutes, life science research companies, and other end users, with life science research companies holding the largest market share in 2023.

Geographical Analysis of the Cell Therapy Instrument Market

The geographical scope of the cell therapy instrument market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

The United States stands out as the largest and fastest-growing market for cell therapy instruments, driven by increased research and development and the rising adoption of cell therapies, including gene, stem cell, and immune therapies. Furthermore, government support is significantly contributing to the growth of cell therapies, positively impacting market expansion. For instance, the American Society of Gene & Cell Therapy (ASGCT) is a public organization that offers memberships to scientists, physicians, professionals, and patient advocates involved in gene and cell therapies, aiming to enhance knowledge, education, and awareness regarding the clinical applications of these therapies.

Scope of the Cell Therapy Instrument Market Report

Recent Developments in the Cell Therapy Instrument Market

The evaluation of the cell therapy instrument market is based on qualitative and quantitative data collected through primary and secondary research, including significant corporate publications, association data, and databases. Recent developments in the market include:

  • Thermo Fisher Scientific and robotics company Multiply Labs have entered into an agreement to enhance their collaboration in automating cell therapy production. (Source: Thermo Fisher Scientific, 2024).
  • MaxCyte has launched the ExPERT instrument family to provide a comprehensive technological platform for next-generation cellular therapies from concept to commercialization. (Source: MaxCyte, Press Release, 2024).

Report Coverage and Deliverables for the Cell Therapy Instrument Market

The report titled "Cell Therapy Instrument Market Size and Forecast (2021-2031)" offers an in-depth analysis of the market, covering the following areas:

  • Market size and forecast at global, regional, and country levels for all key market segments included in the scope.
  • Market dynamics, including drivers, restraints, and key opportunities.
  • Key future trends.
  • Comprehensive PEST/Porter's Five Forces and SWOT analysis.
  • Global and regional market analysis highlighting key trends, major players, regulations, and recent developments.
  • Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments.
  • Detailed company profiles.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Cell Therapy Instruments Market and By Product
    • 1.3.2 Cell Therapy Instruments Market and By Cell Type
    • 1.3.3 Cell Therapy Instruments Market and By Process
    • 1.3.4 Cell Therapy Instruments Market and By End User
    • 1.3.5 Global Cell Therapy Instruments Market and By Geography

2. Cell Therapy Instruments Market and Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Cell Therapy Instrumentsand Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America and PEST Analysis
    • 4.2.2 Europe and PEST Analysis
    • 4.2.3 Asia Pacific and PEST Analysis
    • 4.2.4 Middle East and Africa (MEA) and PEST Analysis
    • 4.2.5 South and Central America (SCAM) and PEST Analysis
  • 4.3 Expert Opinions

5. Cell Therapy Instruments Market and Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Developments in Cell Therapy Manufacturing
    • 5.1.2 Rising Number of Approvals for Cell-based Therapies
  • 5.2 Market Restraints
    • 5.2.1 High Cost Of Cell Therapy Production and Cell Therapy
  • 5.3 Market Opportunities
    • 5.3.1 Growth Opportunities in Developing Regions
  • 5.4 Future Trends
    • 5.4.1 Shift Toward Automated Manufacturing
  • 5.5 Impact Analysis

6. Cell Therapy Instruments Market and Global Analysis

  • 6.1 Global Cell Therapy Instrument Marker Revenue Forecast And Analysis
  • 6.2 Global Cell Therapy Instruments Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Cell Therapy Instruments Market Analysis and By Product

  • 7.1 Overview
  • 7.2 Cell Therapy Instruments Market Revenue Share, by Product (2024 and 2031)
  • 7.3 Consumables
    • 7.3.1 Overview
    • 7.3.2 Consumables: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Equipment
    • 7.4.1 Overview
    • 7.4.2 Equipment: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
    • 7.4.3 Singleanduse Equipment
      • 7.4.3.1 Overview
      • 7.4.3.2 Singleanduse Equipment: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
    • 7.4.4 Cell Processing Equipment
      • 7.4.4.1 Overview
      • 7.4.4.2 Cell Processing Equipment: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
    • 7.4.5 Other Equipment
      • 7.4.5.1 Overview
      • 7.4.5.2 Other Equipment: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Systems and Software
    • 7.5.1 Overview
    • 7.5.2 Systems and Software Segment: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)

8. Cell Therapy Instruments Market Analysis and By Cell Type

  • 8.1 Overview
  • 8.2 Cell Therapy Instruments Market Revenue Share, by Cell Type (2024 and 2031)
  • 8.3 Human Cells
    • 8.3.1 Human Cells: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
    • 8.3.2 Differentiated Cells
      • 8.3.2.1 Overview
      • 8.3.2.2 Differentiated Cells: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
    • 8.3.3 Stem Cells
      • 8.3.3.1 Overview
      • 8.3.3.2 Stem Cells: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Animal Cells
    • 8.4.1 Overview
    • 8.4.2 Animal Cells : Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)

9. Cell Therapy Instruments Market Analysis and By Process

  • 9.1 Overview
  • 9.2 Cell Therapy Instruments Market Revenue Share, by Process (2024 and 2031)
  • 9.3 Cell Processing
    • 9.3.1 Cell Processing: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Process Monitoring and Quality Control
    • 9.4.1 Process Monitoring and Quality Control: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Cell Preservation, Distribution, and Handling
    • 9.5.1 Cell Preservation, Distribution, and Handling: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)

10. Cell Therapy Instruments Market Analysis and By End User

  • 10.1 Overview
  • 10.2 Cell Therapy Instruments Market Share, by End Users, 2024 and 2031, (%)
  • 10.3 Research Institutes
    • 10.3.1 Overview
    • 10.3.2 Research Institutes: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Life Science Research Companies
    • 10.4.1 Overview
    • 10.4.2 Life Science Research Companies : Cell therapy instruments market and Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Other End Users
    • 10.5.1 Overview
    • 10.5.2 Other End Users: Cell therapy instruments market and Revenue and Forecast to 2031 (US$ Million)

11. Cell Therapy Instruments Market Analysis And Forecast to 2031 and Geographical Analysis

  • 11.1 North America: Cell Therapy Instruments Market
    • 11.1.1 Overview
    • 11.1.2 North America: Cell Therapy Instruments Market,- Revenue and Forecast to 2031 (USD Million)
    • 11.1.3 North America: Cell Therapy Instruments Market, by Product and Revenue and Forecast to 2031 (USD Million)
      • 11.1.3.1 North America: Equipment Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 11.1.4 North America: Cell Therapy Instruments Market, by Cell Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.4.1 North America: Human Cells Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 11.1.5 North America: Cell Therapy Instruments Market, by Process and Revenue and Forecast to 2031 (USD Million)
    • 11.1.6 North America: Cell Therapy Instruments Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 11.1.7 North America: Cell Therapy Instruments Market, by Country, 2024 and 2031 (%)
    • 11.1.8 US: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.1 US: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.2 US: Cell Therapy Instruments Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 11.1.8.2.1 US: Equipment Market,, by Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.3 US: Cell Therapy Instruments Market, by Cell Type and Revenue and Forecast to 2031 (USD Million)
        • 11.1.8.3.1 US: Human Cells Market, by Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.4 US: Cell Therapy Instruments Market, by Process and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.5 US: Cell Therapy Instruments Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 11.1.9 Canada: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.1 Canada: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.2 Canada: Cell Therapy Instruments Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 11.1.9.2.1 Canada: Equipment Market,, by Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.3 Canada: Cell Therapy Instruments Market, by Cell Type and Revenue and Forecast to 2031 (USD Million)
        • 11.1.9.3.1 Canada: Human Cells Market,, by Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.4 Canada: Cell Therapy Instruments Market, by Process and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.5 Canada: Cell Therapy Instruments Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 11.1.10 Mexico: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.1 Mexico: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.2 Mexico: Cell Therapy Instruments Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 11.1.10.2.1 Mexico: Equipment Market,, by Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.3 Mexico: Cell Therapy Instruments Market, by Cell Type and Revenue and Forecast to 2031 (USD Million)
        • 11.1.10.3.1 Mexico: Human Cells Market,, by Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.4 Mexico: Cell Therapy Instruments Market, by Process and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.5 Mexico: Cell Therapy Instruments Market, by End User and Revenue and Forecast to 2031 (USD Million)
  • 11.2 Europe: Cell Therapy Instruments Market
    • 11.2.1 Overview
    • 11.2.2 Europe: Cell Therapy Instruments Market - Revenue and Forecast to 2031 (USD Million)
    • 11.2.3 Europe: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
      • 11.2.3.1 Europe: Equipment Market, by Type, 2024 and 2031 (USD Millions)
    • 11.2.4 Europe: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
      • 11.2.4.1 Europe: Human Cells Market, by Type, 2024 and 2031 (USD Million)
    • 11.2.5 Europe: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
    • 11.2.6 Europe: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.7 Europe: Cell Therapy Instruments Market, by Country, 2019 and 2031 (%)
    • 11.2.8 Germany: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.8.1 Germany: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.8.2 Germany: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.2.8.2.1 Germany: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.2.8.3 Germany: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.2.8.3.1 Germany: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.8.4 Germany: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.2.8.5 Germany: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.9 France: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.9.1 France: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.9.2 France: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.2.9.2.1 France: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.2.9.3 France: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.2.9.3.1 France: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.9.4 France: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.2.9.5 France: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.10 UK: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.10.1 UK: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.10.2 UK: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.2.10.2.1 UK: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.2.10.3 UK: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.2.10.3.1 UK: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.10.4 UK: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.2.10.5 UK: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.11 Italy: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.11.1 Italy: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.11.2 Italy: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.2.11.2.1 Italy: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.2.11.3 Italy: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.2.11.3.1 Italy: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.11.4 Italy: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.2.11.5 Italy: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.12 Spain: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.12.1 Spain: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.12.2 Spain: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.2.12.2.1 Spain: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.2.12.3 Spain: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.2.12.3.1 Spain: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.12.4 Spain: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.2.12.5 Spain: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
  • 11.3 Asia Pacific: Cell Therapy Instruments Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Cell Therapy Instruments Market - Revenue and Forecast to 2031 (USD Million)
    • 11.3.3 Asia Pacific: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
      • 11.3.3.1 Asia Pacific: Equipment Market, by Type, 2024 and 2031 (USD Millions)
    • 11.3.4 Asia Pacific: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
      • 11.3.4.1 Asia Pacific: Human Cells Market, by Type, 2024 and 2031 (USD Million)
    • 11.3.5 Asia Pacific: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
    • 11.3.6 Asia Pacific: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.7 Asia Pacific: Cell Therapy Instruments Market, by Country, 2019 and 2031 (%)
    • 11.3.8 China: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.8.1 China: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.8.2 China: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.3.8.2.1 China: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.3.8.3 China: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.3.8.3.1 China: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.8.4 China: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.3.8.5 China: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.9 Japan: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.9.1 Japan: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.9.2 Japan: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.3.9.2.1 Japan: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.3.9.3 Japan: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.3.9.3.1 Japan: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.9.4 Japan: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.3.9.5 Japan: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.10 India: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.10.1 India: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.10.2 India: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.3.10.2.1 India: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.3.10.3 India: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.3.10.3.1 India: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.10.4 India: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.3.10.5 India: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.11 South Korea: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.11.1 South Korea: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.11.2 South Korea : Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.3.11.2.1 South Korea : Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.3.11.3 South Korea : Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.3.11.3.1 South Korea : Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.11.4 South Korea : Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.3.11.5 South Korea : Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.12 Australia: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.12.1 Australia: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.12.2 Australia: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.3.12.2.1 Australia: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.3.12.3 Australia: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.3.12.3.1 Australia: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.12.4 Australia: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.3.12.5 Australia: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
  • 11.4 Middle East and Africa: Cell Therapy Instruments Market
    • 11.4.1 Overview
    • 11.4.2 Middle East and Africa: Cell Therapy Instruments Market - Revenue and Forecast to 2031 (USD Million)
    • 11.4.3 Middle East and Africa: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
      • 11.4.3.1 Middle East and Africa: Equipment Market, by Type, 2024 and 2031 (USD Millions)
    • 11.4.4 Middle East and Africa: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
      • 11.4.4.1 Middle East and Africa: Human Cells Market, by Type, 2024 and 2031 (USD Million)
    • 11.4.5 Middle East and Africa: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
    • 11.4.6 Middle East and Africa: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.4.7 Middle East and Africa: Cell Therapy Instruments Market, by Country, 2019 and 2031 (%)
    • 11.4.8 UAE: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.8.1 UAE: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.8.2 UAE: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.4.8.2.1 UAE: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.4.8.3 UAE: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.4.8.3.1 UAE: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.4.8.4 UAE: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.4.8.5 UAE: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.4.9 Saudi Arabia: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.9.1 Saudi Arabia: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.9.2 Saudi Arabia: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.4.9.2.1 Saudi Arabia: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.4.9.3 Saudi Arabia: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.4.9.3.1 Saudi Arabia: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.4.9.4 Saudi Arabia: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.4.9.5 Saudi Arabia: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.4.10 South Africa: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.10.1 South Africa: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.10.2 South Africa: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.4.10.2.1 South Africa: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.4.10.3 South Africa: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.4.10.3.1 South Africa: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.4.10.4 South Africa: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.4.10.5 South Africa: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
  • 11.5 South and Central America: Cell Therapy Instruments Market
    • 11.5.1 Overview
    • 11.5.2 South and Central America: Cell Therapy Instruments Market - Revenue and Forecast to 2031 (US$ Million)
    • 11.5.3 South and Central America: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
      • 11.5.3.1 South and Central America: Equipment Market, by Type, 2024 and 2031 (USD Millions)
    • 11.5.4 South and Central America: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
      • 11.5.4.1 South and Central America: Human Cells Market, by Type, 2024 and 2031 (USD Million)
    • 11.5.5 South and Central America: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
    • 11.5.6 South and Central America: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.5.7 South and Central America: Cell Therapy Instruments Market, by Country, 2019 and 2031 (%)
    • 11.5.8 Brazil: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.8.1 Brazil: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.8.2 Brazil: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.5.8.2.1 Brazil: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.5.8.3 Brazil: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.5.8.3.1 Brazil: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.5.8.4 Brazil: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.5.8.5 Brazil: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
    • 11.5.9 Argentina: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.9.1 Argentina: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.9.2 Argentina: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
        • 11.5.9.2.1 Argentina: Equipment Market, by Type, 2024 and 2031 (USD Millions)
      • 11.5.9.3 Argentina: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
        • 11.5.9.3.1 Argentina: Human Cells Market, by Type, 2024 and 2031 (USD Million)
      • 11.5.9.4 Argentina: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
      • 11.5.9.5 Argentina: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)

12. Impact of COVID-19 Pandemic on Global Cell Therapy Instruments Market

  • 12.1 North America: Impact Assessment of COVID-19 Pandemic
  • 12.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 THERMO FISHER SCIENTIFIC INC.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 MERCK KGaA
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Lonza
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 General Electric Company
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Terumo Corporation
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 BD
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Miltenyi Biotec
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 STEMCELL Technologies Inc.
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Sartorius AG
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Danaher (Beckman Coulter, Inc.)
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 Glossary of Terms